1-6 of 6
Mark B. Juckett, MD
Close
Sort by
Journal Articles

Utilization of Leftover Autologous Peripheral Blood Stem Cells (PBSCs) in Patients with Multiple Myeloma (MM)

Natalie S Callander, MD, Walter L. Longo, MD, Mark B. Juckett, MD, Vaishalee P. Kenkre, MD, Peiman Hematti, MD, Janelle McMannes, Rebecca K Evans, Linda A Eckstein, MSN,NP, Blythe Gage, NP
Journal: Blood
Blood (2014) 124 (21): 2654.
https://doi.org/10.1182/blood.V124.21.2654.2654
Published: 2014
Journal Articles

Recovery Of Natural Killer Cells and Monocyte Subsets Following Autologous Peripheral Blood Stem Cell Transplantation Predicts Longer Progression Free Survival Among Multiple Myeloma Patients

Natalie S Callander, MD, Paul J Rathouz, PhD, Fotis Asimakopoulos, MBBChir, PhD, Mark B Juckett, MD, Christopher L Coe, PhD, Dagna Sheerar, BS, Karen Ersland, PhD, Peiman Hematti, MD, Erin S Costanzo, PhD
Journal: Blood
Blood (2013) 122 (21): 2126.
https://doi.org/10.1182/blood.V122.21.2126.2126
Published: 2013
Journal Articles

Reducing the Risk for Transplant Related Mortality After Allogeneic Hematopoietic Cell Transplantation: How Much Progress Has Been Made?.

John Horan, MD, MPH, Brent R. Logan, PhD, Manza-A. Agovi, MPH, Hillard M Lazarus, MD, Andrea Bacigalupo, MD, Karen Ballen, Rodrigo Martino, Mark B. Juckett, MD, Hanna J. Khoury, MD, Christopher Bredeson, MD, Vikas Gupta, Franklin O. Smith, MD, Gregory Hale, Matthew Carabasi, MD, Philip L. McCarthy, MD, J. Douglas Rizzo, MD, MS, Marcelo C. Pasquini, MD
Journal: Blood
Blood (2009) 114 (22): 649.
https://doi.org/10.1182/blood.V114.22.649.649
Published: 2009
Journal Articles

The Addition of Bevacizumab (B) to Lenalidomide and Low Dose Dexamethasone Does Not Significantly Increase Response in Relapsed or Refractory Multiple Myeloma (NCI#7317).

Natalie Scott Callander, MD, Stephanie Markovina, BA, Mark B. Juckett, MD, Elizabeth Wagner, MA, Jill Kolesar, Walter Longo, Eliot C. Williams, MD, PhD, Kyungmann Kim, Jae Werndli, BSc, MSc, Shigeki Miyamoto, PhD
Journal: Blood
Blood (2009) 114 (22): 3885.
https://doi.org/10.1182/blood.V114.22.3885.3885
Published: 2009
Journal Articles

A Pilot Study for Using 3′-Deoxy-3′-[ 18 f]Fluorothymidine Positron Emission Tomography ([18F]FLT PET/CT) Imaging for Early Assessment of Response to Induction Chemotherapy in Acute Myeloid Leukemia (AML)

Mark B. Juckett, MD, Matt Vanderhoek, Scott Perlman, Robert Nickles, Robert Jeraj
Journal: Blood
Blood (2008) 112 (11): 2550.
https://doi.org/10.1182/blood.V112.11.2550.2550
Published: 2008
Journal Articles

Thalidomide (HAL) Maintenance Following High-Dose Melphalan with Autologous Stem Cell Transplant (ASCT) for Myeloma.

Julie E. Chang, MD, Mark B. Juckett, MD, Brad S. Kahl, MD, Teri L. Mitchell, Ronald E. Gangnon, PhD, Natalie S. Callander, MD, Walter L. Longo, MD
Journal: Blood
Blood (2006) 108 (11): 5455.
https://doi.org/10.1182/blood.V108.11.5455.5455
Published: 2006